EP300 and posterior cortical atrophy: These observations provide a preclinical proof-of-concept that agents inhibiting the CBP/p300 HAT function may be effective for treating PCa and that a combination of CBP/p300 HAT and BD inhibitors may be synergistic in blocking CBP/p300 function [28].